Western Health is one of the largest providers of Maternity Services in Australia, delivering approximately 6500+ women annually at Sunshine Hospital JKWC, whilst supporting pregnancy care, labour and birth, post-natal and in home care services for pregnant women and their families.
Since 2013 there has been a specialist Maternal Fetal Medicine Service based at Sunshine Hospital, supporting the increasing complexities of pregnancies and birth, with a major focus on pregnancy, fetal and birth outcomes research for both mother and baby.
Our Maternal Fetal Medicine Research team includes highly experienced MFM Specialists, Obstetricians and Research Coordinators/Midwives. Our unit develops and coordinates both Australian and International clinical trials and participates in a myriad of MFM/Obstetric Investigator led and Sponsored studies.
We believe all pregnant women should be given the opportunity to participate in research as a means of potentially improving both theirs and their babies’ outcomes and contribute to improving evidence-based care for all women.
Current Active Recruiting Trials:
C*STEROID Antenatal corticosteroids prior to planned caesarean section delivery from 35+0 to 39+6 weeks gestation: a randomised controlled trial assessing the effects on neonatal respiratory morbidity and glycaemic control Sponsor: University of Melbourne Principal Investigator: A/Prof Joanne Said Funding: MRFF International Clinical Trials Collaboration
iSEARCH – Can intrapartum Sildenafil Citrate safely avert the risks of contraction-induced hypoxia in labour? iSEARCH – a pragmatic multicentre Phase III randomised controlled trial. Sponsor: University of Sydney Principal Investigator: A/Prof Joanne Said Funding: Medical Research Futures Fund, NHMRC, Australian Cerebral Palsy Alliance and the Royal Australian and New Zealand College of Obstetricians and Gynaecologist’s Women’s health Foundation
PROTECT Me – A triple-blinded, randomized, parallel-group placebo-controlled trial (PROTECT Me trial) to assess the impact of maternal antenatal melatonin supplementation on early childhood neurodevelopmental outcomes in the setting of severe preterm fetal growth restriction. Sponsor: Monash University Principal Investigator: Dr SuLynn Khong Funding: Monash Partners Equity Trustee’s
Page last updated 06 November 2023
